Net Cash Provided by (Used in) Financing Activities in USD of NAVIDEA BIOPHARMACEUTICALS, INC. from 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2023.
  • Navidea Biopharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$201K, a 40.9% increase year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $7.14M, a 41% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $12.1M, a 18.6% increase from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $10.2M, a 65.9% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$201K +$139K +40.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 -$339K -$8.31M -104% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $7.97M +$7.4M +1298% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $570K +$637K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 -$67K +$51.2K +43.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 -$118K +$60.6M +99.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 -$60.8M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2015 $3.5M +$267K +8.27% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q1 2014 $3.23M -$5.25M -61.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $8.48M +$8.49M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q1 2012 -$7.39K* -$5.14M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $5.13M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10

NAVIDEA BIOPHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $7.14M -$4.97M -41% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $12.1M +$1.9M +18.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $10.2M +$4.05M +65.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $6.16M +$10.7M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-26
2018 -$4.55M +$56.4M +92.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-18
2017 -$61M -$51.9M -567% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
2016 -$9.14M -$29.9M -144% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $20.8M +$17.6M +551% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $3.19M -$57.5M -94.7% Jan 1, 2014 Dec 31, 2014 8-K 2017-12-15
2013 $60.7M +$55.7M +1098% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-16
2012 $5.07M -$6.01M -54.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $11.1M +$4.73M +74.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $6.35M Jan 1, 2010 Dec 31, 2010 10-K/A 2013-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.